Certican

Certican (Everolimus) is an oral medication used to prevent organ rejection after transplants. It works by suppressing the immune system to help the body accept the transplanted organ.

Certican is primarily used to prevent rejection of transplanted organs, such as kidneys, liver, or heart. It is often prescribed to patients who have undergone organ transplantation to help their bodies accept the new organ. The medication works by suppressing the immune system's response to the transplanted organ, reducing the risk of rejection.

Common effects of Certican may include headaches, nausea, and fatigue. Some users may also experience swelling, high blood pressure, or changes in blood sugar levels. It is important to discuss any persistent or severe side effects with a healthcare provider.

Certican should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should avoid activities that require alertness until they know how the medication affects them.

Certican may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is important to inform healthcare providers about all medications being taken, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider.